Indole derivatives as serotonin reuptake inhibitors

Details Indole derivatives as serotonin reuptake inhibitors Indole derivatives as serotonin reuptake inhibitors

2004-05-24

2010-11-09

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S358000

Reexamination Certificate

active

07829565

ABSTRACT:
Compounds of the formula (I), the use thereof for the preparation of a medicament for the treatment of diseases associated with the serotonin receptor and/or serotonin reuptake, in particular for the preparation of a medicament as anxiolytic, antidepressant, neuroleptic and/or antihypertonic and/or for positively influencing obsessive-compulsive disorder (OCD), sleeping disorders, tardive dyskinesia, learning disorders, age-dependent memory disorders, eating disorders, such as bulimia, and/or sexual dysfunctions. The compounds bind to the 5-HT1Areceptor.

REFERENCES:
patent: 2004/0147528 (2004-07-01), Bathe et al.
patent: 2006/0122191 (2006-06-01), Heinrich et al.
patent: 2006/0160824 (2006-07-01), Heinrich et al.
patent: 10353657 (2005-06-01), None
patent: WO 02/39989 (2002-05-01), None
patent: WO 02/102794 (2002-12-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
Greene. Protective Groups in Organic Synthesis, 1999, pp. 17-23.
March. Advanced Organic Chemistry, 1992, pp. 357-362.
Farvolden et al. Expert Opinion on Investigational Drugs, 2003, 12(1), 65-86.
Pillay et al. Expert Opinion on Investigational Drugs, 2007, 12(4), 541-54.
Legos et al. Expert Opinion on Investigational Drugs, 2002, 11(5), 603-614.
Waeber Expert Opinion on Investigational Drugs, 2003, 8(2), 437-56.
Schurks. Expert Opinion on Drug Metabolism Toxicology, 2009, 5(9), 1141-48.
Grigoriadis. Expert Opinion in Therapeutic Targets, 2009, 9(4), pp. 651-684.
Czlonkowska et al. Expert Opinion in Pharmacotherapy, 2009, 10(8), pp. 1249-1259.

Affiliated with

Also associated with

Rating

Indole derivatives as serotonin reuptake inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole derivatives as serotonin reuptake inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives as serotonin reuptake inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4193696